Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Am J Geriatr Psychiatry. 2013 Feb 6;21(10):10.1016/j.jagp.2013.01.046. doi: 10.1016/j.jagp.2013.01.046

Table 2.

Medication adherence at four-month follow-up.

Adjusted for demographic characteristics1 Adjusted for demographic characteristics and illness burden2 Adjusted for demographic characteristics, illness burden, and functional status3

Group Comparison Odds Ratio 95%CI Wald Test P value OddsRatio 95%CI Wald Test p value Odds Ratio 95%CI Wald Test p value
African-American 1.0 -- -- -- 1.0 -- -- -- 1.0 -- -- --
White 2.47 (1.32-- 4.62) 2.82 0.0048 2.12 (1.05-- 4.32) 2.08 0.0372 2.02 (0.95-- 4.30) 1.82 0.0685

African-American female 1.0 -- -- -- 1.0 -- -- -- 1.0 -- -- --
African-American male 1.64 (0.67-- 4.02) 1.08 0.2807 1.76 (0.69-- 4.53) 1.18 0.2393 2.15 (0.79-- 5.81) 1.50 0.1329
White male 2.55 (1.06-- 6.13) 2.09 0.0368 2.31 (0.89-- 6.00) 1.72 0.0860 2.48 (0.90-- 6.85) 1.75 0.0805
White female 3.69 (1.57-- 8.67) 2.99 0.0028 3.26 (1.27-- 8.33) 2.46 0.0138 3.58 (1.27-10.07) 2.42 0.0157
1

adjusted for demographic variables of age, marital status, and education.

2

adjusted for demographic variables and illness burden variables of prior treatment of depression, number of prescribed medications, physical component summary score (PCS), mental component summary score (MCS), depression score on patient health questionnaire (PHQ total), hospital anxiety depression score (HADS total), and anxiety sensitivity index (ASI total).

3

adjusted for demographic variables, illness burden variables, and functional status variables of Katz index of independence in activities of daily living (KATZ total), instrumental activities of daily living (IADL total), and Weschler memory scale.